GCTK vs LRCX · P/E 0.1, $4.1M cap vs P/E 71, rev $23.23B
GlucoTrack Inc (GCTK) versus Lam Research Corp (LRCX) — a side-by-side from cached financials, not a winner call.
GlucoTrack Inc (GCTK) is a medical instruments & supplies company listed on US.
Lam Research Corp (LRCX) is a semiconductor equipment & materials company listed on NASDAQ. It is led by Timothy M. Archer.
GCTK does not have a complete income-statement cache yet.
Latest reported LRCX revenue for 2026-06-28 was $23.23B. Net income was $7.27B. LRCX currently screens at market cap $467.94B and trailing P/E 70.9.
GCTK currently screens at market cap $4.1M and trailing P/E 0.1. LRCX currently screens at market cap $467.94B and trailing P/E 70.9.
Not investment advice. Open the GCTK and LRCX stock pages for the full models.
Not investment advice.